Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Journal of Medicinal Chemistry|January 21, 2016
Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free TechnologyPaula Morales, Lauren S Whyte, Roberto Chicharro, et al.Bioorganic & Medicinal Chemistry|January 30, 2002
Long-acting fentanyl analogues: synthesis and pharmacology of N-(1-phenylpyrazolyl)-N-(1-phenylalkyl-4-piperidyl)propanamidesNadine Jagerovic, Carolina Cano, José Elguero, et al.European Journal of Medicinal Chemistry|November 18, 2005
Structural-activity relationship study on C-4 carbon atom of the CB1 antagonist SR141716: synthesis and pharmacological evaluation of 1,2,4-triazole-3-carboxamidesNadine Jagerovic, Laura Hernandez-Folgado, Ibon Alkorta, et al.ACS Medicinal Chemistry Letters|June 18, 2014
Discovery of Potent Dual PPARα Agonists/CB1 LigandsRuth Pérez-Fernández, Nieves Fresno, Manuel Macías-González, et al.Bioorganic & Medicinal Chemistry|October 28, 2008
Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agentsMario Alvarado, Pilar Goya, Manuel Macías-González, et al.Plos One|December 2, 2014
Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1Nieves Fresno, Ruth Pérez-Fernández, Carlos Goicoechea, et al.Journal of Medicinal Chemistry|May 14, 2004
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motifNadine Jagerovic, Laura Hernandez-Folgado, Ibon Alkorta, et al.Bioorganic & Medicinal Chemistry|February 26, 2013
Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21Mario Alvarado, Juan Decara, María Jesús Luque, et al.European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.Journal of Medicinal Chemistry|June 17, 2016
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple SclerosisPaula Morales, María Gómez-Cañas, Gemma Navarro, et al.Pageof 4